News

Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving ...
After earning a dual MD–PhD from the University of Maryland, Porter used his background in muscle cell biology to investigate heart development at Yale. It wasn’t until his move to Rochester, however, ...
A medical breakthrough could result in the first treatment for rare but serious diseases in which genetic defects disrupt ...
Scientists from the Centre National De La Recherche Scientifique in France and from Hawai’i have discovered that it is ...
Clinically Inspired Mitochondrial Support Supplement Mitolyn Faces Real Consumer Feedback and Scientific Scrutiny—Here’s What ...
Growing research now suggests that for many people, the real issue isn't simply excess calories or inactivity but rather a ...
TACOMA, Wash., April 08, 2025 (GLOBE NEWSWIRE) -- For years, I’d been searching for something—anything—that could give me real, lasting energy without the inevitable crash. I tried ...
Mitochondrial diseases, arising from mutations in mitochondrial DNA (mtDNA), are a diverse group of disorders that lead to severe conditions. Expression of mtDNA is a prerequisite for ATP production ...
Mitochondrial diseases caused by POLG mutations ... conducted at GoCo Health Innovation City and its headquarters located in Waltham, Massachusetts, just outside Boston.
Mitochondrial diseases caused by POLG mutations ... conducted at GoCo Health Innovation City and its headquarters located in Waltham, Massachusetts, just outside Boston.